Jon Williams is the Executive Director at Cuidiú Ltd. He specializes in themes such as cannabis and psychedelics, finance, trading, and arts and entertainment, while also covering broader topics like social issues and government politics. Jon's work has been featured in prominent publications including the Las Vegas Review-Journal, Ad Age, and The Drum.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Jon Williams' articles predominantly focus on investment analysis and press releases related to stock market activities, particularly OTC stocks. Therefore, he is likely to be receptive to pitches that offer unique insights into OTC stock performance or company news.
Given the nature of his coverage, Jon would likely welcome expert commentary from financial analysts or industry insiders with deep knowledge of specific companies and their market performance. Additionally, providing data-driven insights or exclusive interviews with key figures within the companies covered could be appealing to him.
It's evident that Jon does not have a specific geographic focus but rather concentrates on analyzing global stock market trends and company performances across various industries.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jon Williams
In August, SBA proposed new rules on a wide range of topics. Some of the proposed rules, like the significant changes to the recertification rules that we blogged about here, have been getting most of the headlines so far. The purpose of this client alert is to put the spotlight on one of the less talked about proposals, a seemingly minor proposed change to how SBA calculates annual receipts.
On Thursday, there were a number of companies that had seen their stocks clock significant gains, and one such company was Telesis Bio (NASDAQ: TBIO), which saw
Medcana (OTC:SFWJ) saw its stock take a bit of a battering yesterday and record a decline of 22% amidst a strong selloff.What Happened?On Wednesday, Med
On Wednesday, the CREATD Inc. (OTC:CRTD) stock emerged as one of the notable movers as it clocked gains of 11% following an announcement about one of its portfo
Following the announcement from the company on Thursday, the Cannabis Sativa Inc. (OTC:CBDS) stock was in sharp focus among investors and ended up with gains of
By: Jon Williams
There are certain stocks that are expected to be in sharp focus this morning, and one of those is likely to be the CeriBell (NASDAQ: CBLL) stock, which delivere
By: Jon Williams
In light of the developments from yesterday, it is likely that the PickleJar Entertainment Group Inc. (OTC:PKLE) stock is going to be in focus this morning. It
Welcome to planet Cheshire East everyone, where decisions are made which ignore what residents want to happen and are blatantly ignored, is there a mathematician in the house?
Prospective, RandomiZed Controlled Trial of Cataract Surgery Vs Combined Cataract Surgery with Insertion of iStent Inject
By: Kelly Kirchgasser, Daniel Figuenick,, Joseph Loman, Krissy Cralle, Jon Williams, Cole Fox, Abigail Finan, Nichole Atallah, Abigail Baker, Meghan Leemon, Lauren Brier, Isaias Alba, Iv, Sarah Nash
December 2024: Reducing the Negative Impacts of a Government Shutdown for Federal Contractors - Once again, the specter of a government...
(833) 317-6278 
